EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable insulin pen ended with an anticlimax Monday. The order formally dismissing the ...
California’s CalRx insulin pens will launch Jan. 1 at $11 each, or $55 for a five-pack The state has invested $100 million to lower insulin costs The effort could save patients $2,000 to $4,000 a year ...
California to Launch Insulin for Just $11 a Pen The new CalRx insulin will work as a generic version of glargine and could save patients $2,000 to $4,000 per year ...
California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for folks with diabetes. The ...
MONDAY, Oct. 20, 2025 (HealthDay News) — California will start selling low-cost insulin Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more ...